Cadrenal Therapeutics, Inc.'s market cap is currently $28.57M. The company's EPS TTM is $-1.87; its P/E ratio is ―; Cadrenal Therapeutics, Inc. is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-1.55. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Currency in USD
Cadrenal Therapeutics, Inc. Earnings and Revenue History
